6-(Hydroxymethyl)pyridine-3-boronic acid → 2,2-dichloro-1-((4S,5R)-4-(fluoromethyl)-5-(4-(6-(hydroxymethyl)pyridin-3-yl)phenyl)-2,2-dimethyloxazolidin-3-yl)ethanone
Reaktionsgleichung
[Cl:1][CH:2]([Cl:21])[C:3]([N:5]1[C@H:9]([CH2:10][F:11])[C@@H:8]([C:12]2[CH:17]=[CH:16][C:15](I)=[CH:14][CH:13]=2)[O:7][C:6]1([CH3:20])[CH3:19])=[O:4].[OH:22][CH2:23][C:24]1[N:29]=[CH:28][C:27](B(O)O)=[CH:26][CH:25]=1>>[Cl:1][CH:2]([Cl:21])[C:3]([N:5]1[C@H:9]([CH2:10][F:11])[C@@H:8]([C:12]2[CH:17]=[CH:16][C:15]([C:27]3[CH:28]=[N:29][C:24]([CH2:23][OH:22])=[CH:25][CH:26]=3)=[CH:14][CH:13]=2)[O:7][C:6]1([CH3:20])[CH3:19])=[O:4]Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
Following the general procedure of Example 1—Step 1 and making non-critical variations but using 2,2-dichloro-1-((4S,5R)-4-(fluoromethyl)-5-(4-iodophenyl)-2,2-dimethyloxazolidin-3-yl)ethanone and (6-(hydroxymethyl)pyridin-3-yl)boronic acid as starting materials the title compound is obtained (800 mg): m/z (Cl) M−H 426.1.
Quellen und Nachweise
- ORD-Eintrag
- ord-ccfa438a75084f05ae10a2cc9e9278e9
- Quelldatensatz
- uspto-grants-2015_07
- Patentnummer
- US09073894B2
Notizen zur Reaktion
Wird geladen…